School personnel information

写真b

Hayakawa Hideki


Organization 【 display / non-display

  • 2013.04.01 - , Division of Medicine, Graduate School of Medicine, Specially Appointed Researcher

 

Academic Papers 【 display / non-display

  • A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo, Nakamori M, Panigrahi GB, Lanni S, Gall-Duncan T, Hayakawa H, Tanaka H, Luo J, Otabe T, Li J, Sakata A, Caron MC, Joshi N, Prasolava T, Chiang K, Masson JY, Wold MS, Wang X, Lee MYWT, Huddleston J, Munson KM, Davidson S, Layeghifard M, Edward LM, Gallon R, Santibanez-Koref M, Murata A, Takahashi MP, Eichler EE, Shlien A, Nakatani K, Mochizuki H, Pearson CE, Nat Genet, 2020.02, Papers

  • Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology, Hayakawa H, Nakatani R, Ikenaka K, Aguirre C, Choong CJ, Tsuda H, Nagano S, Koike M, Ikeuchi T, Hasegawa M, Papa SM, Nagai Y, Mochizuki H, Baba K, Mov Disord, 2019.10, Papers

  • E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease, Sakai R, Suzuki M, Ueyama M, Takeuchi T, Minakawa EN, Hayakawa H, Baba K, Mochizuki H, Nagai Y, PLoS One, 2019.06, Papers

  • Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease., Uehara T, Choong CJ, Nakamori M, Hayakawa H, Nishiyama K, Kasahara Y, Baba K, Nagata T, Yokota T, Tsuda H, Obika S, Mochizuki H, Scientific reports,9(1) 7567, 2019.05, Other

  • MarmoDetector: A Novel 3D Automated System for the Quantitative Assessment of Marmoset Behavior, Yabumoto T, Yoshida F, Miyauchi H, Baba K, Tsuda H, Ikenaka K, Hayakawa H, Koyabu N, Hamanaka H, Papa SM, Hirata M, Mochizuki H, J Neurosci Methods,1(322) 23-33, 2019.04, Papers

display all >>